Jie Xie

Safety and Clinical Activity of SHR7390 Monotherapy or Combined With Camrelizumab for Advanced Solid Tumor: Results From Two Phase I Trials

Fenghua Wang, Yu-hong Li, R. Xu, 2022, The oncologist.